Assay for identifying compounds which affect stability of mRNA

Details for Australian Patent Application No. 2005229165 (hide)

Owner Novation Pharmaceuticals Inc.

Inventors Cheneval, Dominique; Kastelic, Tania

Agent Fisher Adams Kelly

Pub. Number AU-A-2005229165

PCT Pub. Number WO2005/095615

Priority 10/814,634 01.04.04 US

Filing date 1 April 2005

Wipo publication date 13 October 2005

International Classifications

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

23 November 2006 PCT application entered the National Phase

  PCT publication WO2005/095615 Priority application(s): WO2005/095615

21 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005229202-Device for supplying cooling air to a moving blade

2005229162-Refractory articles for quiding or conveying a solidified material and process for the manufacture thereof